Elanco Animal Health Reports Fourth Quarter and Full Year 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
Elanco Animal Health (ELAN) Tops Q4 EPS by 88c, Offers Guidance
February 24, 2022 6:34 AM ESTElanco Animal Health (NYSE: ELAN) reported Q4 EPS of $1.05, $0.88 better than the analyst estimate of $0.17. Revenue for the quarter came in at $1.11 billion versus the consensus estimate of $1.1 billion.
GUIDANCE:
Elanco Animal Health sees Q1 2022 EPS of $0.33-$0.38, versus the... More
